Interstitial Lung Disease
- Patient-centered Outcomes Research in Interstitial Lung Disease: An Official American Thoracic Society Research Statement (2021)
- Home Oxygen Therapy for Adults with Chronic Lung Disease: An Official ATS Clinical Practice Guideline (2020)
- Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline (2020)
- Diagnosis and Detection of Sarcoidosis. An Official ATS Clinical Practice Guideline (2020)
- Knowledge Gaps and Research Priorities in Immune Checkpoint Inhibitor–related Pneumonitis. An Official ATS Research Statement (2019)
- Diagnosis of IPF: An Official ATS/ERS/JRS/ALAT Guideline (2018)
- Lymphangioleiomyomatosis Diagnosis and Management Part I and II: An Official ATS/JRS Clinical Practice Guideline (2016/2017)
- Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis: An Official ATS Workshop Report (2017)
- Future Directions in Lung Fibrosis Research: An Official ATS Research Statement (2016)
- Interstitial Pneumonia with Autoimmune Features: An ATS/ERS Research Statement (2015)
- Treatment of IPF: An Official ATS/ERS/JRS/ALAT Guideline (2015)
- Field Walking Tests in Chronic Respiratory Disease: Official ATS/ERS Technical Standards (2014)
- Measurement Properties of Field walking Tests in Chronic Respiratory Disease: An Official ATS/ERS Systematic Review (2014)
- The Choosing Wisely Top 5 List in Adult Pulmonary Medicine: An Official ATS/ACCP Statement (2014)
- Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias: An Official ATS/ERS Statement (2013)
- The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis In Interstitial Lung Disease: An Official ATS Clinical Practice Guideline (2012)
- Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management: An Official ATS/ERS/JRS/ALAT Statement (2011)
- NIH/NHLBI Notice re: 3-drug Regimen for IPF (2011)
